Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study)

<p>Abstract</p> <p>Background</p> <p>Acute Coronary Syndromes account for 15% of deaths in the UK, and patients remain at significant risk of re-admission for future complications and death. Pathologically the underlying process of atherosclerosis is driven by inflammat...

Full description

Bibliographic Details
Main Authors: Flather Marcus D, Lucking Andrew J, Fox Keith AA, Hall Alistair S, Greenwood John P, Gunn Julian P, Morton Allison C, Crossman David C, Lees Belinda, Foley Claire E
Format: Article
Language:English
Published: BMC 2008-02-01
Series:Trials
Online Access:http://www.trialsjournal.com/content/9/1/8